Ipsen is a finished-dose manufacturer based in France. It appears in 555 regulatory filings across 26 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, AIFA (IT) and MHRA (UK). Its GMP standing is certified by ANSM (FR), MFDS (Korea) and EMA.
| Site | FDA FEI |
|---|---|
| Zug, Switzerland | Not on file |
| L 'ISLE SUR LA SORGUE, France | Not on file |
| Dreux, France | Not on file |
| Lisle Sur La Sorgue, France | Not on file |
| Paris, France | Not on file |
| Tlalnepantla de Baz, Mexico | Not on file |
2 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 92 | 1 |
| AIFA (IT) | 51 | None |
| MHRA (UK) | 44 | None |
| FAMHP (BE) | 34 | None |
| MPA (SE) | 32 | None |
| INFARMED (PT) | 32 | None |
| ANSM (FR) | None | 25 |
| MFDS (Korea) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $118.3M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Ipsen comes back tiered against every other supplier able to file there.
Start for free